Edition:
India

Fagron NV (FAGRO.BR)

FAGRO.BR on Brussels Stock Exchange

16.46EUR
18 Jul 2018
Change (% chg)

€-0.04 (-0.24%)
Prev Close
€16.50
Open
€16.50
Day's High
€16.55
Day's Low
€16.43
Volume
11,365
Avg. Vol
168,103
52-wk High
€16.85
52-wk Low
€10.02

Chart for

About

Fagron NV, formerly Arseus NV, is a Belgium-based company that is active in the healthcare sector. It operates as a research and development (R&D) scientific pharmaceutical compounding supplier and operates through four segments: The Fagron Specialty Pharma Services segment comprises personalized medication that is produced in... (more)

Overall

Beta: 1.82
Market Cap(Mil.): €1,165.36
Shares Outstanding(Mil.): 71.84
Dividend: 0.10
Yield (%): 0.43

Financials

  FAGRO.BR Industry Sector
P/E (TTM): 25.11 29.21 33.15
EPS (TTM): 0.65 -- --
ROI: 10.00 13.66 13.23
ROE: 28.18 15.51 15.27

BRIEF-Fagron Reports Q1 Turnover At 109.1 Million Euros

* Q1 TURNOVER EUR 109.1 MILLION VERSUS EUR 109.0 MILLION YEAR AGO

12 Apr 2018

French and Benelux stocks-Factors to watch on April 4

April 4 Below are company-related news and stories from French and Benelux media which could have an impact on the region's markets or individual stocks.

04 Apr 2018

BRIEF-Humco And Fagron To Combine For Up To 70 Million Dollars

* ‍GREGORY PULIDO, HUMCO'S CHAIRMAN AND CHIEF EXECUTIVE OFFICER, WILL TRANSITION TO ROLE OF EXECUTIVE CHAIRMAN​

03 Apr 2018

BRIEF-Fagron Acquires Humco in United States

* FAGRON STRENGTHENS STRATEGIC POSITION IN USA THROUGH HIGHLY COMPLEMENTARY ACQUISITION OF HUMCO

03 Apr 2018

BRIEF-Fagron FY Rebitda Increased 5.7% To 95.7 Million Euros

* REG-FAGRON TURNOVER INCREASED BY 3.6% TO € 436.9 MILLION AND NET PROFIT INCREASED TO € 47.0 MILLION

07 Feb 2018

Earnings vs. Estimates